Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- 1-A Offering statement
- PART II AND III Part II and III
- EX1A-3 HLDRS RTS Loan Agreement Dated September 1, 2017 Between the Company and Emerald Health Sciences Inc
- EX1A-3 HLDRS RTS Amendment Agreement Dated January 26, 2018 Between the Company and Emerald Health Sciences Inc.
- EX1A-4 SUBS AGMT Form of Subscription Agreement
- EX1A-6 MAT CTRCT Intellectual Property Transfer Agreement Dated June 15, 2017, Between the Company and Vivacell Biotechnology Espana S.L.
- EX1A-6 MAT CTRCT Collaborative Research Agreement Dated June 15, 2017, Between the Company and Vivacell Biotechnology Espana S.L.
- EX1A-6 MAT CTRCT Consulting Agreement Dated June 15, 2017, Between the Company and University of Cordoba, Eduardo Munoz Blanco
- EX1A-6 MAT CTRCT Form of Indemnification Agreement for Officers and Directors
- EX1A-6 MAT CTRCT 2018 Equity Incentive Plan of the Company
- EX1A-11 CONSENT Consent of Deloitte & Touche LLP
- EX1A-12 OPN CNSL Opinion of Morrison & Foerster LLP
- PDF Testing the Waters Materials
Emerald Health Pharmaceuticals similar filings
External links